Page last updated: 2024-11-04

rofecoxib and Brain Edema

rofecoxib has been researched along with Brain Edema in 2 studies

Brain Edema: Increased intracellular or extracellular fluid in brain tissue. Cytotoxic brain edema (swelling due to increased intracellular fluid) is indicative of a disturbance in cell metabolism, and is commonly associated with hypoxic or ischemic injuries (see HYPOXIA, BRAIN). An increase in extracellular fluid may be caused by increased brain capillary permeability (vasogenic edema), an osmotic gradient, local blockages in interstitial fluid pathways, or by obstruction of CSF flow (e.g., obstructive HYDROCEPHALUS). (From Childs Nerv Syst 1992 Sep; 8(6):301-6)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tan, DS1
Evanson, J1
Plowman, PN1
Chew, SL1
Hewett, SJ1
Silakova, JM1
Hewett, JA1

Other Studies

2 other studies available for rofecoxib and Brain Edema

ArticleYear
Post-radiation inflammatory reaction controlled with thalidomide and rofecoxib.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2004, Volume: 16, Issue:8

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Brain Edema; Brain Neoplasms; Female; Hemangioblasto

2004
Oral treatment with rofecoxib reduces hippocampal excitotoxic neurodegeneration.
    The Journal of pharmacology and experimental therapeutics, 2006, Volume: 319, Issue:3

    Topics: Animals; Blotting, Western; Brain Edema; Cell Death; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inh

2006